3,631 results match your criteria: "Angiomyolipoma Kidney"
Radiographics
January 2025
From the Departments of Radiology (L.C.J., P.J.N., D.A., S.M.T., E.T., G.S., T.P., S.K.V., T.D.A.), Urology (A.M.P.), and Radiation Oncology (B.S.), Mayo Clinic, 200 First St SW, Rochester, MN 55905.
In patients with renal masses, when intervention is warranted, partial nephrectomy is preferred when feasible, especially for T1 renal masses. Thermal ablation, however, has become an accepted alternative treatment of small renal neoplasms with excellent oncologic outcomes. The National Comprehensive Cancer Network guidelines include thermal ablation as a treatment strategy for managing T1a and select T1b masses.
View Article and Find Full Text PDFEinstein (Sao Paulo)
December 2024
Urology Department, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, SP, Brazil.
We report a case of computed tomography-guided percutaneous radiofrequency ablation of a bleeding renal angiomyolipoma. Radiofrequency ablation was performed as an alternative to partial nephrectomy and super-selective renal artery embolization for ruptured renal angiomyolipoma with slow persistent bleeding in a patient with elevated serum creatinine levels and other comorbidities. Computed tomography-guided radiofrequency ablation successfully stopped the active hemorrhage and did not affect long-term renal function during the 3-year follow period.
View Article and Find Full Text PDFUrol Case Rep
January 2025
Department of the Emergency Medicine, State Security Service Military Hospital, Baku, Azerbaijan.
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms, commonly found in the uterus and retroperitoneum. Renal PEComas are exceedingly rare, often posing diagnostic challenges due to their resemblance to renal cell carcinoma (RCC) on imaging. We present the case of an 18-year-old male who presented with non-specific symptoms of fever, chills, and shivering.
View Article and Find Full Text PDFTrop Doct
December 2024
Professor, Department of Pulmonary Medicine, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
Angiomyolipomas are the benign tumours of the kidney which occur either sporadically or in association with tuberous sclerosis complex (TSC). Symptoms typically develop with an increase in the size of the lesion. We present a clinical image of a patient with giant renal angiomyolipomas who had other clinical features of TSC (facial angiofibromas, periungual fibroma, subependymal nodules in the brain, and lung cysts).
View Article and Find Full Text PDFClin Nucl Med
December 2024
From the Department of Nuclear Medicine, University of Health Sciences, Kartal Dr Lutfi Kirdar City Hospital, Istanbul, Turkey.
J Surg Case Rep
November 2024
Department of Surgery, Jawaharlal Nehru Medical College, Medical College Road, Aligarh Muslim University, Aligarh 202002, India.
Angiomyolipoma is a benign mesenchymal tumour of kidney that consists of adipose tissue, muscle cells and blood vessels. Renal angiomyolipomas represent almost one percent of all renal tumours. We reported a case of a 50-year-old woman complaining of mild abdominal discomfort with no other symptoms and no remarkable medical history.
View Article and Find Full Text PDFWorld J Clin Oncol
November 2024
Department of Andrology, Huzhou Women and Children's Hospital, Huzhou 313000, Zhejiang Province, China.
Seizure
December 2024
Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN, United States; Tuberous Sclerosis Center of Excellence, Le Bonheur Children's Hospital, Memphis, TN, United States; Division of Pediatric Neurology, University of Tennessee Health Science Center, 49 North Dunlap, 3rd Floor FOB, Memphis, TN 38105, United States. Electronic address:
Introduction: Individuals with tuberous sclerosis complex (TSC) often present with refractory epilepsy and may be undergoing treatment with vagus nerve stimulation (VNS) to control seizures. Surveillance magnetic resonance imaging (MRI) is necessary to monitor for the renal angiomyolipomas associated with TSC; however, MRI of the abdomen is not approved for patients withVNS therapy. We have many TSC patients with refractory epilelpsy who benefitted from VNS therapy, so we developed an MRI protocol that allows MRI of the abdomen to be performed in these patients to permit safe imaging of their kidneys.
View Article and Find Full Text PDFAust J Gen Pract
November 2024
MBBS, PhD, FRACS (Urol), Professor, Department of Surgery, The University of Melbourne, Melbourne, Vic; Founding Director, EJ Whitten Prostate Cancer Research Centre at Epworth Healthcare, Melbourne, Vic;@Head of Unit, Department of Urology, The Royal Melbourne Hospital, Melbourne, Vic.
Urol Clin North Am
February 2025
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston 02114, MA, USA.
Renal cell carcinoma (RCC) is a growing problem in global oncology, with a steadily increasing incidence, especially in developed regions. Its different histologic subtypes present different challenges in diagnosis and management. Advanced imaging techniques have a crucial role in distinguishing between these subtypes by highlighting unique radiographic features such as exophytic growth patterns, cystic components, and enhancement patterns.
View Article and Find Full Text PDFEur J Pediatr
November 2024
UCL Great Ormond Street Institute of Child Health, University College London, London, UK.
Transl Androl Urol
October 2024
Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, China.
Cureus
October 2024
Pathology, Multiprofile Hospital for Active Treatment, Shumen, BGR.
Renal leiomyomas are rare benign mesenchymal tumors that arise from the smooth muscle cells in the renal capsule, renal pelvis, and the smooth muscles of vessels in the kidney. They are usually found by accident during autopsies or on different imaging modalities made on other occasions. The clinical presentation may include hematuria and abdominal or flank pain, although renal leiomyomas are most frequently asymptomatic.
View Article and Find Full Text PDFBMC Nephrol
October 2024
Department of Pediatrics, Division of Nephrology, Saint Louis University, 1465 S Grand Blvd, St. Louis, MO, 62104, USA.
Background: Tuberous Sclerosis complex (TSC) is a multisystemic neurocutaneous genetic condition with high rates of morbidity and mortality from subependymal giant cell astrocytoma (SEGA), renal angiomyolipoma, and renal cyst complications. Everolimus is an inhibitor for mTORC1 and is currently used to treat TSC for its main role in rapidly reducing SEGA volume and seizure burden, although mainly studied in the adult population. It has also been shown to stabilize estimated glomerular filtration rate and reduce renal angiomyolipoma size in the adult population.
View Article and Find Full Text PDFInt J Surg Case Rep
November 2024
Department of Medical Imaging and Radiology, Nepal Mediciti Hospital, Nepal.
Introduction: Renal angiomyolipoma is the most common benign kidney tumor, representing 1-3 % of solid renal tumors. Despite its benign nature, it can be associated with lethal hemorrhage, and can also show signs of local extension mimicking malignant tumors. The cornerstone of treatment remains angioembolization and nephron sparing surgery.
View Article and Find Full Text PDFBMC Urol
October 2024
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, China.
Background: For renal hilar angiomyolipoma, general surgical resection is often quite challenging. The aim of this study is to evaluate the safety and efficacy of an innovative robot-assisted laparoscopic strategy that combines tumor enucleation with tumor aspiration in the treatment of renal hilar angiomyolipoma.
Methods: The clinical data of 38 patients with renal hilar angiomyolipoma who went through robotic tumor enucleation combined with tumor aspiration in the Department of Urology, the Affiliated Hospital of Nanjing University Medical School, from December 2019 to December 2022 were retrospectively analyzed.
Head Neck Pathol
October 2024
Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
Eur J Pediatr
December 2024
Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
Sci Rep
September 2024
Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, No. 158, Shangtang Road, Gongshu District, Hangzhou, 310014, Zhejiang, China.
With the continuous development of robot-assisted technology, Robot-assisted Laparoscopic Partial Nephrectomy (RALPN) has gradually become an optional method for the treatment of Hemorrhage secondary to angiomyolipoma (HSA). However, there are rare clinical reports of the primary RALPN for HSA. Therefore, this research aims to evaluate the efficacy and safety of primary RALPN for HSA.
View Article and Find Full Text PDFCell Mol Biol Lett
September 2024
Department of Pathophysiology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, Liaoning, People's Republic of China.
Abdom Radiol (NY)
September 2024
Dokuz Eylül University, Izmir, Turkey.
Indian J Surg Oncol
September 2024
Department of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.
Renal angiomyolipoma (AML), also referred to as renal hamartoma, is a rare solid tumor without malignant characteristics. The inheritance pattern of renal AML is autosomal dominant. If the lesion grows to a large size, a series of clinical manifestations and serious complications may occur.
View Article and Find Full Text PDFEur J Radiol
December 2024
Department of Radiology B, University Hospital of Strasbourg - New Civil Hospital, 1 place de l'Hôpital, BP 426, Strasbourg, 67091 Cedex, France. Electronic address:
World J Urol
September 2024
Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, PR China.
Background: We aimed to launched new staging criteria to predict mTOR inhibitors treatment effect of renal angiomyolipomas (r-AMLs) in TSC patients.
Methods: 40 TSC patients with 69 r-AMLs were divided into two groups based on the efficacy of 6-month mTOR inhibitor treatment. Epidemiological data, therapeutic response, and predictive factors of enrolled patients were collected and analyzed.